California Public Employees Retirement System Paratek Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.81 - $10.93 $604,047 - $969,491	-88,700 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$4.58 - $7.14 $8,702 - $13,566	-1,900 Reduced 2.1%	88,700 $555,000
Q3 2020 Nov 05, 2020	BUY	$4.19 - $6.69 $33,939 - $54,189	8,100 Added 9.82%	90,600 $490,000
Q2 2020 Aug 12, 2020	BUY	$2.97 - $5.22 $48,114 - $84,564	16,200 Added 24.43%	82,500 $431,000
Q1 2020 May 12, 2020	SELL	$2.67 - $4.97 $148,719 - $276,829	-55,700 Reduced 45.66%	66,300 $209,000
Q3 2019 Oct 31, 2019	BUY	$3.08 - $5.76 $20,636 - $38,592	6,700 Added 5.81%	122,000 $527,000
Q4 2018 Feb 08, 2019	SELL	$4.8 - $11.6 $26,908 - $65,029	-5,606 Reduced 4.64%	115,300 $591,000
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $4,579 - $5,540	506 Added 0.42%	120,906 $1.17 Million
Q1 2018 May 11, 2018	BUY	$12.65 - $18.85 $1.52 Million - $2.27 Million	120,400 New	120,400 $1.57 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account